Park Edge Advisors’s Merck MRK Stock Holding History
Bought
Maintained
Sold
Other funds holding MRK
LMFP
AAMU
CRM
SP
ORIO
CNB
Park Edge Advisors's MRK Position: Q2 2026 in Review
Park Edge Advisors increased its Merck (MRK) stake by 4.8% in Q2 2026, buying an estimated $23.4K and bringing the position to 4,378 shares worth $563K. The position accounts for 0.12% of the portfolio, ranked #100.
Park Edge Advisors first reported a position in MRK in Q4 2022 and has held it in 15 quarters since. The position peaked at $1.31M in Q4 2023. 711 funds tracked by Wall St. Rank hold MRK as of Q2 2026.
- Park Edge Advisors held 4,378 shares of Merck worth $563K as of Q2 2026.
- Park Edge Advisors bought 200 Merck shares in Q2 2026, an estimated $23.4K.
- Merck made up 0.12% of Park Edge Advisors's portfolio in Q2 2026, its #100 holding.
- Park Edge Advisors first reported a position in Merck in Q4 2022 and has held it in 15 quarters since.
- Park Edge Advisors's Merck position peaked at $1.31M in Q4 2023.
- 711 funds tracked by Wall St. Rank held Merck as of Q2 2026.
Based on Park Edge Advisors's 13F filing for Q2 2026, filed 13 Jul 2026.